Similarly, when ROP was subcutaneously administered using PF-72 (a reverse thermal hydrogel), its concentration–time curve (AUClast) and peak concentration (Cmax) were much lower than those after administration of ROP solution [32]. This evidence concerns the gene OPN1LW and retinopathy of prematurity.